Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
This study is ongoing, but not recruiting participants.
Study NCT00350545   Information provided by Stanford University

First Received on July 5, 2006.   Last Updated on July 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graft vs Host Disease
Blood and Marrow Transplant (BMT)
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
Rituximab
Prednisone
cyclosporine A
tacrolimus
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Inflammatory Agents
Antifungal Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Stanford University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services